Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Bresnihan

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Arthritis Research & Therapy|December 19, 2003
Are synovial biopsies of diagnostic value?Barry Bresnihan
The Journal of Rheumatology. Supplement|September 19, 2002
Preventing joint damage as the best measure of biologic drug therapyBarry Bresnihan
The Journal of Rheumatology. Supplement|November 19, 2002
Rheumatoid arthritis: principles of early treatmentBarry Bresnihan
Current Opinion in Rheumatology|June 10, 2006
Synovial biomarkers in the spondylarthropathiesBarry Bresnihan
Current Opinion in Rheumatology|June 6, 2008
Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategiesJoseph Keane, Barry Bresnihan
Rheumatic Diseases Clinics of North America|March 15, 2003
Infection complications associated with the use of biologic agentsBarry Bresnihan, Gaye Cunnane
Rheumatology (Oxford, England)|September 24, 2009
Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritisPatricia Minnock, John Kirwan, Barry Bresnihan
Best Practice & Research. Clinical Rheumatology|June 6, 2003
Infections and biological therapy in rheumatoid arthritisGaye Cunnane, Michele Doran, Barry Bresnihan
Arthritis and Rheumatism|April 11, 2003
Quality of life, social support, and knowledge of disease in women with rheumatoid arthritisPatricia Minnock, Oliver Fitzgerald, Barry Bresnihan
Clinical Rheumatology|February 22, 2008
Measurement of periarticular bone mineral density in the hands of patients with early inflammatory arthritis using dual energy x-ray absorptiometryEithne Murphy, Barry Bresnihan, Oliver FitzGerald
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Arthritis Research & Therapy|December 19, 2003
Are synovial biopsies of diagnostic value?Barry Bresnihan
The Journal of Rheumatology. Supplement|September 19, 2002
Preventing joint damage as the best measure of biologic drug therapyBarry Bresnihan
The Journal of Rheumatology. Supplement|November 19, 2002
Rheumatoid arthritis: principles of early treatmentBarry Bresnihan
Current Opinion in Rheumatology|June 10, 2006
Synovial biomarkers in the spondylarthropathiesBarry Bresnihan
Current Opinion in Rheumatology|June 6, 2008
Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategiesJoseph Keane, Barry Bresnihan
Rheumatic Diseases Clinics of North America|March 15, 2003
Infection complications associated with the use of biologic agentsBarry Bresnihan, Gaye Cunnane
Rheumatology (Oxford, England)|September 24, 2009
Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritisPatricia Minnock, John Kirwan, Barry Bresnihan
Best Practice & Research. Clinical Rheumatology|June 6, 2003
Infections and biological therapy in rheumatoid arthritisGaye Cunnane, Michele Doran, Barry Bresnihan
Arthritis and Rheumatism|April 11, 2003
Quality of life, social support, and knowledge of disease in women with rheumatoid arthritisPatricia Minnock, Oliver Fitzgerald, Barry Bresnihan
Clinical Rheumatology|February 22, 2008
Measurement of periarticular bone mineral density in the hands of patients with early inflammatory arthritis using dual energy x-ray absorptiometryEithne Murphy, Barry Bresnihan, Oliver FitzGerald
Pageof 7